Search company, investor...

Ventyx Biosciences

ventyxbio.com

Founded Year

2019

Stage

IPO | IPO

Total Raised

$165M

Date of IPO

10/21/2021

Market Cap

2.20B

Stock Price

37.60

About Ventyx Biosciences

Ventyx Biosciences (NASDAQ:VTYX) is a biotechnology company that develops differentiated therapeutics that target both the innate and adaptive immune systems.

Headquarters Location

662 Encinitas Blvd Suite 250

Encinitas,California,92024,

United States

Missing:Ventyx Biosciences'sProduct Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing:Ventyx Biosciences'sProduct & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing Ventyx Biosciences

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Ventyx Biosciences in1 CB Insights research brief, most recently onAug 5, 2021.

Ventyx BiosciencesPatents

Ventyx Biosciences has filed 3 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Immune system
  • Signal transduction
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/5/2020

Clusters of differentiation, Tyrosine kinases, Signal transduction, Immune system, Transcription factors

Application

Application Date

11/5/2020

Grant Date

Title

Related Topics

Clusters of differentiation, Tyrosine kinases, Signal transduction, Immune system, Transcription factors

Status

Application

Ventyx BiosciencesFrequently Asked Questions (FAQ)

  • When was Ventyx Biosciences founded?

    Ventyx Biosciences was founded in 2019.

  • Where is Ventyx Biosciences's headquarters?

    Ventyx Biosciences's headquarters is located at 662 Encinitas Blvd, Encinitas.

  • What is Ventyx Biosciences's latest funding round?

    Ventyx Biosciences's latest funding round is IPO.

  • How much did Ventyx Biosciences raise?

    Ventyx Biosciences raised a total of $165M.

  • Who are the investors of Ventyx Biosciences?

    Investors of Ventyx Biosciences include Vivo Capital, Farallon Capital Management, Surveyor Capital, OrbiMed Advisors, Third Point and 10 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions withour sites and services. Use of these cookies, which may be stored on your device,permits us to improve and customize your experience. You can read more about yourcookie choices at our privacy policyhere. By continuing to use thissite you are consenting to these choices.

Baidu
map